Also, thought they'd substitute the topical spray with the gel, given they have indicated that the gel is likely the better formulation.
Maybe it was too late to change the trial. Or they are still optimising the gel formulation before using it in a clinical trial.
Ann: Patients Dosed in R327 Diabetic Foot Infection Trial, page-6
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $108.4M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 39.0¢ | 36.5¢ | $39.00K | 102.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9999 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 2108 | 1 |
View Market Depth
| Last trade - 16.10pm 08/08/2025 (20 minute delay) ? |
| RCE (ASX) Chart |